US Patent 8426428 EGFR kinase knockdown via electrophilically enhanced inhibitors
Patent 8426428 was granted and assigned to Principia Biopharma Inc. on April, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 5, 2008
0
Date of Patent
April 23, 2013
0
Patent Application Number
12329445
0
Patent Citations Received
Patent Inventor Names
Richard Miller
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8426428 EGFR kinase knockdown via electrophilically enhanced inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
